###### Strengths and limitations of this study

-   This is both the first 'mixed-methods' study within the area of radiotherapy training and the first study involving both trainers and trainees in the UK; therefore, the protocol for this approach merits replication and/or adaptation in other UK centres in the future.

-   The questionnaire design involved several national figures in radiotherapy medical education, and as the Centre at the focus of the proposed study is regarded as contemporary, therefore, all investigators believe that recommendations from the study will be widely applicable.

-   This is the first study focusing solely on radiotherapy in the Clinical Oncology model of training and thus, this study's results will provide feedback specifically to those responsible for radiotherapy teaching at local, regional and national levels.

-   There is a risk of the lead researcher's unilateral perspective as a trainee influencing the results despite mindfulness for reflexivity.

Introduction {#s1}
============

Clinical oncologists care for patients with cancer by overseeing the delivery of their radiotherapy (RT) and systemic anticancer treatments (SACT) such as chemotherapy, endocrine therapy, targeted agents and immunotherapy. Trainees spend at least 5 years under supervision before being accredited to practice independently. The training follows an apprenticeship model and is centred around day-to-day delivery of care, theoretical preparation courses, departmental group teaching and personal study.[@R1] The practical nature of RT means that developing clinical competencies relies on experience in the workplace, and Clinical Oncology has been described as a craft specialty,[@R2] with trainees and trainers assuming an apprenticeship-like relationship.[@R4] The last two decades have brought greatly improved RT outcomes for many patient groups through improved understanding of radiobiology and technological advances in computing and engineering.[@R6] In preparing for ultimately taking up consultant posts, trainees must be familiar with the scientific principles of RT, for example, physics and radiobiology, the modern treatment techniques, and also the more conventional techniques.[@R1]

In 2005, the Modernising Medical Careers' initiative reformed postgraduate medical training, standardising the pathways to a career as a consultant in Clinical Oncology.[@R7] Around the same time, enforcement of the European Working Time Directive affected working patterns and rota structures for trainees.[@R8] The expansion of the Clinical Oncology consultant workforce also began to influence medical team structure.[@R9] As a result of such adjustments on the background of a multifactorial national shortage of junior doctors,[@R10] it is common for Clinical Oncology trainees to provide middle-grade cover for inpatients of several consultants simultaneously and attend multiple systemic therapy clinics each week, thereby regularly missing RT learning opportunities.[@R3] This is reflected in a recent study that found new consultants feel under-prepared for independent RT practice when they take up their first post.[@R11]

Although supervised and systematic practice in hospitals facilitates the acquisition of competences, knowledge and skills, doctors are ultimately responsible for their own learning as members of training programmes.[@R12] Educational agreements between trainees and their trainers require bilateral engagement and proactivity.[@R13] In the last decade, documentation of learning has become increasingly important in the UK with the introduction of the ePortfolio system,[@R14] which has served to formalise educational supervision[@R15] and assessments.[@R16]

All UK doctors are also charged with the responsibility of teaching under the principles of Good Medical Practice as laid out by the General Medical Council.[@R18] Professional revalidation procedures stipulate that active participation in education programmes must be demonstrated at 5-yearly appraisals.[@R19] The Royal College of Radiologists (RCR) recognises the need for workplace-based training in its incorporation of dedicated teaching time in job planning recommendations for consultants[@R21] and in its vision for the evolution of the specialty.[@R22]

The effects of the evolution in cancer outcomes and progress in RT techniques in recent decades have been studied by few educationalists in the UK, or further afield.[@R23] The natural focus on clinical research in this small hospital discipline partly accounts for this. The limited recent research available on training in general in Clinical Oncology suggests that the transformations in the RT landscape have had an impact on training.[@R3] This proposed research is a dedicated study of RT training among Clinical Oncology specialty trainees and consultants at a regional cancer centre to elicit their views on the current strengths and weaknesses of modern RT learning.

Methods and analysis {#s2}
====================

Aims {#s2-1}
----

1.  To qualify the strengths and weaknesses of RT learning at a regional cancer centre by assessing the views of trainees and trainers using semistructured interviews.

2.  To quantify the strengths and weaknesses using a questionnaire of both trainers and trainees.

3.  To identify differences between trainer and trainee perceptions of modern RT learning.

Study design {#s2-2}
------------

This is a mixed-methods research project with two phases of investigation. Phase I will consist of semistructured interviews with five trainers and five trainees. Phase II will comprise a questionnaire survey of all 36 trainers and trainees. For this study, all Clinical Oncology consultants are regarded as 'trainers' and all specialty trainees are regarded as 'trainees'.

Interpretive phenomenological analysis (IPA) will be performed on the qualitative data generated in phase I. Descriptive statistics will be applied to the quantitative data generated in phase II, and thematic analysis will be employed for phase II qualitative information. Phase I will establish the strengths and weaknesses of modern RT learning from a sample of Clinical Oncology doctors at Cancer Centre Belfast City Hospital (BCH) and phase II will generate numerical data on the entire population of Clinical Oncology doctors. The results from both phases will be considered in a pooled manner and also by trainer/trainee status to assess for practically significant differences between the experience and opinion of trainers compared with trainees. The original study proposal was developed iteratively following review by faculty members of Centre for Medical Education (CME) at Queen's University Belfast (QUB) and presentation at a CME Research Fellow Seminar.

Methods: phase I {#s2-3}
----------------

Semistructured interviews allow the researcher to start with a planned open question and subsequently discuss unplanned threads of discourse depending on the interviewee's responses.[@R29] The aim is to elicit details about RT learning settings from the perspectives of the trainee and the trainer, and how the training arrangements interact with the elements of RT practice perceived as easy or difficult to learn. Participants will be given the opportunity to describe their experiences, state their positive and negative opinions on modern RT learning and what they would change to improve it. Trainer and trainees will answer the same stem questions ([figure 1](#F1){ref-type="fig"}) except for one question which applies only to trainers (indicated). The order in which the stems are asked will depend on the course of each individual dialogue, in keeping with the principles of semistructured interview. The number of stems introduced will depend on the duration of the interviewee's previous responses, as the lead investigator will aim to keep interview duration to approximately 40 min in total. At the completion of the semistructured interview, the participants' involvement will be concluded.

![Stem interview questions.](bmjopen-2020-037171f01){#F1}

IPA will enable the lead investigator to elicit information about the lived experience of trainers and trainees, in part by 'bracketing' of his own exposure to RT learning to date.[@R30] Bracketing refers to the placement of ones' own judgements and perceptions aside, and approaching the presented information factually and neutrally, aiming to unpack the underlying detail logically. Advantages of this analysis include depth of output, catalysed by the lead investigator's informed contextual position of currently being in a Clinical Oncology training post. The lead investigator has been trained in the scientific rationale, practical requirements and conventional regulations of conducting semistructured interviews and conducting IPA during his successful completion of the Methods in Educational Enquiry module undertaken at QUB, as part of the Masters in Clinical Education. The research team will endeavour to apply the principles laid out in the COnsolidated criteria for REporting Qualitative research recommendations.[@R33]

Methods: phase II {#s2-4}
-----------------

Phase II data collection will be in the form of a questionnaire 4 weeks after completion of phase I ([online supplementary appendices 1 and 2](#SP1 SP2){ref-type="supplementary-material"}). The questionnaire was initially developed once key concepts to capture were agreed by the core research team ([figure 2](#F2){ref-type="fig"}). The preliminary draft was iteratively developed using a combination of resources: Clinical Oncology curriculum, the Oncology Registrar's Forum (ORF) 2017 training survey, the annual General Medical Council Training Survey and feedback from trusted colleagues (four trainers and three trainees), two members of the UK-wide ORF Survey Group, the ARENA Clinical Research Fellow in Wales and the Training Programme Director (TPD) for Clinical Oncology training in Northern Ireland. No validated questionnaires have been published to date in this field, most likely due to the lack of enthusiasm for medical education studies in RT learning, and because of the relatively small size of the specialty in each country.
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![Outline of framework for questionnaire design and development.](bmjopen-2020-037171f02){#F2}

Several questions (and answers) of the questionnaire in this study have been aligned with the ORF's recent national survey[@R34] to provide an indication of generalisability. The level of detail in each question item was tailored according to its importance as perceived by those with input to the drafting of this bespoke questionnaire. Response options were carefully tailored for questions on an individual basis, with the use of subjective options in several questions to improve their accessibility for the full range of experience and age within the study population. Important issues raised during phase I that have been omitted from the provisionally approved questionnaire will be added if a supportive consensus is reached by the research team on a question-by-question basis. The research ethics committee will be consulted for approval of the updated questionnaire prior to phase II recruitment.

Questionnaires will be distributed to participants following their confirmation of interest by email response. Paper questionnaires have been chosen over digital formats as the investigators agree that this will yield a better response rate, taking into account the range of levels of seniority among the study population. Completion of questionnaires will take 15 min and the return of the consent form and questionnaire to a collection box by phase II participants will mark the end of study participation. The collection box will be checked for responses each working day. Results will be recorded with the unique identifier (ranging from 000 to 034) but there is no planned data linkage with phase I or any other datasets. Responses will be transposed to Microsoft Excel and any free-text comments will be recorded in the same spreadsheet.

Descriptive statistics will be applied to summarise the responses and these will be assessed as a pooled group of Clinical Oncology clinicians. The thematic analysis technique will be applied to qualitative questions. This will permit the lead investigator to establish themes among the factors that improved or detracted from the experienced quality of RT learning to date, whether ongoing or previously completed. Coded data resulting from the thematic analysis will allow investigators to organise interview contents in meaningful categories.[@R35] Parallels drawn between the described learning environments and the interviewees' accounts of positive or negative aspects may assist in identifying methods to enhance the strengths of modern RT learning and improve any weaknesses identified. The guidance provided for reporting of qualitative survey outcomes will be taken from the SRQR recommendations.[@R36]

Recruitment {#s2-5}
-----------

Recruitment for both phases will begin with an email invitation to all trainers and trainees working at Cancer Centre BCH by hospital email. The email for phase I will describe the study in brief and have the relevant study information and consent form linked as attachments. A date, time and location for an interview will be confirmed by email correspondence with the first five trainee and five trainer respondents to register interest. A reserve list of two trainers and trainees will be kept for phase I should some participants have a change in circumstance and two reminder emails will be sent following original invitations, 1 week apart. For phase II, an envelope with the unique 3-digit study number displayed containing the study information, consent form and the questionnaire including instructions will be delivered to the respondents. There will be no limit to the number of participants in phase II. It is expected that recruitment will not be difficult as the study has the support of the region's TPD and Educational Supervisors.

Sample size and statistical analysis {#s2-6}
------------------------------------

All specialty trainees (n=13) and consultants (n=21) in Clinical Oncology working at Cancer Centre BCH will be invited to participate in both phases of investigation (investigators excluded). The recruitment target for phase I is based on medical education literature, where a sample of approximately 10 from a homogeneous population is regarded as optimal for conducting IPA.[@R7]

No statistical tests will be performed on phase I data. Descriptive statistics will be applied to phase II data by the lead investigator. Due to differences between trainers' and trainees' average responses in phase II qualitative data, some will have statistical significance tests applied (decided in advance of survey distribution). Given the small population involved and the uncertainty about accrual, the most suitable statistical test cannot be determined in advance. The power and effect size of such statistics also cannot be predetermined given the small size of the study population. The advice was provided by a senior medical statistician associated with the CME.

Potential sources of bias {#s2-7}
-------------------------

It is possible that study participants may not accurately recall details of their training in years past. This may manifest as proportion of 'not sure' responses or possibly inaccurate responses, especially in the questionnaires among trainers and more senior trainees. It is not possible to reduce this bias; however, study participants will be encouraged to be frank in their responses.

Some Clinical Oncology trainees and trainers may not wish to enrol in phase I as their personal accounts are not blinded to the lead investigator, who is their peer or junior. It will be made clear to phase I study participants that all statements made are made in confidence. Phase II study participants will have their data collected anonymously and therefore their relationship with the lead investigator is irrelevant.

Some of the study participants may be involved in the organisation of the RT training programme or have been involved in the past and could be perceived to have a potential conflict of interest. This connection to the subject matter being studied may affect the responses they offer. Whether such a participant declares involvement will be at their discretion, as no interview stem or questionnaire question addresses this point. Some trainers and trainees may feel that it is their responsibility to defend the RT learning at the Cancer Centre BCH from negative feedback, due to personal attachment to the close-knit community of cancer clinicians working there. Participants are informed in the relevant study information documents that the proposed study seeks to objectively identify both the strengths and weaknesses of the training programme.

Training and service provision matters pertaining to systemic therapy will not be addressed in this study, nor will 'soft skills' acquired during specialty training in preparation for a consultant post, such as leadership and communication.

Patient and public involvement {#s2-8}
------------------------------

No patients were involved.

Ethics and dissemination {#s3}
========================

Ethical approval was granted by the School of Medicine, Dentistry and Biological Sciences Research Ethics Committee at QUB (Ref: 17.64). A successful Integrated Research Application System submission was made through the Belfast Health & Social Care Trust to secure research governance for research involving employees (Project ID: 242 591). Overall study sponsorship was agreed by QUB (Ref: A18/03).

The generated results of this mixed-methods study will be shared with the TPD for Clinical Oncology in Northern Ireland, the ORF and the Medical Director for Education and Training at the RCR, so that new findings can be considered in future educational planning both regionally and nationally. The results will also be submitted for publication. Learning points generated from this study may be generalisable and transferrable outside of the UK, given that trainees encounter difficulties in RT education in many countries.[@R24]

To the investigators' knowledge this will be the first research to have been conducted into the learning of RT skills specifically, among trainees who are training in chemotherapy also. It is known that UK trainees will describe challenges in obtaining adequate exposure to RT practice due to competition for their time from outpatient SACT patients and acutely unwell inpatients,[@R3] and therefore, a tailored UK study centred on RT training is warranted. This will be the first UK study where both trainers and trainees participate in the same study of RT training. It is reasonable to expect a higher yield of balanced insights from the study by including both stakeholders involved in the learning process. Furthermore, no mixed-methods research of technical RT training is available in the existing literature. The investigators believe that this feature of the study design will lead them to a deeper understanding of the strengths and weaknesses of RT training compared with questionnaires alone and that any importance of the interaction between trainers and trainees may be elucidated.
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